“You could’t have that safer supply without the need of there remaining a source,” he explained, introducing which they’re predominantly wanting to offer to researchers and front-line employees rather than directly to drug buyers.Safer offer — giving drug buyers lawful use of a offer of cleanse medicines along with health care supervision